FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

WEIL JOHN D		 2. Issuer Name and Ticker or Trading Symbol

ALLIED HEALTHCARE PRODUCTS INC [ AHPI ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

4625 LINDELL BLVD., #335		 3. Date of Earliest Transaction (MM/DD/YYYY)

11/26/2021
(Street)

ST. LOUIS, MO 63108
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/26/2021  S  69249 D$8.437 (1)25178 (2)I Spouse 
Common Stock 11/26/2021  S  59101 D$8.467 (1)0 (3)I Trust 
Common Stock 11/26/2021  S  7514 D$8.0565 (1)0 (4)I Corporation 
Common Stock         53810 (5)I Trust 
Common Stock         90513 D 
 
Common Stock         2500 I IRA 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to purchase common stock $5.09 11/11/2021 11/11/2021 A   750    11/11/2022 11/11/2031 Common stock 750 (6)$0 750 D 
 
Option to purchase common stock $5.18           11/8/2013 11/8/2022 Common stock 750  750 D 
 
Option to purchase common stock $4.62           11/14/2014 11/14/2023 Common stock 750  750 D 
 
Option to purchase common stock $3.16           11/13/2015 11/13/2024 Common stock 750  750 D 
 
Option to purchase common stock $2.34           11/12/2016 11/12/2025 Common stock 750  750 D 
 
Option to purchase common stock $2.26           11/10/2017 11/10/2026 Common stock 750  750 D 
 
Option to purchase common stock $2.22           11/9/2018 11/9/2027 Common stock 750  750 D 
 
Option to purchase common stock $2.13           11/8/2019 11/8/2028 Common stock 750  750 D 
 
Option to purchase common stock $1.17           11/7/2020 11/7/2029 Common stock 750  750 D 
 
Option to purchase common stock $7.86           11/12/2021 11/12/2030 Common stock 750  750 D 
 
Explanation of Responses:
(1) The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(2) The reporting person disclaims any economic benefit in such shares.
(3) Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
(4) Owned by a corporation controlled by the reporting person.
(5) Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares. The decrease of 6,710 reported shares between the amount reported in this filing and the amount reported in the most recent previous filing is due to omission of a trust for which the reporting person no longer serves as trustee and with respect to which the reporting person no longer has any pecuniary interest.
(6) Issued pursuant to the Company's 2013 Director's Stock Option Plan.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
WEIL JOHN D
4625 LINDELL BLVD., #335
ST. LOUIS, MO 63108		X
Signatures
/s/ John D. Weil11/30/2021
**Signature of Reporting PersonDate
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Allied Healthcare Products Charts.
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Allied Healthcare Products Charts.